Barclays Turned Bearish on NuScale Power at a 52-Week Low. Here's the Single Missing Contract That Would Prove It Wrong.

Barclays cut its price target on SMR from $11 to $5, a move that reflects how far the stock has fallen: shares sit 85% below their 52-week high, at a fresh 52-week low.

The bearish turn comes despite SMR securing regulatory approval for its small modular nuclear reactor design. The missing piece is a signed customer contract, which the company needs to validate its business model. Approval without a buyer leaves the commercial case unproven.

Meanwhile, SMR is burning cash while it waits. Two potential deals sit in the pipeline: RoPower in Romania and ENTRA1 Energy in the U.S. Negotiations are expected to run into early 2027, meaning any binding agreement could be many months away.

Interpretation: Barclays' halving of its target to $5 signals the analyst is pricing in extended delay rather than imminent resolution. The cash burn raises the cost of that delay, since each month without a contract draws down resources while the revenue story stays theoretical. A signed deal with either RoPower or ENTRA1 Energy would directly address the central objection behind the downgrade.